• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素C以氧化形式通过葡萄糖转运蛋白穿过血脑屏障。

Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters.

作者信息

Agus D B, Gambhir S S, Pardridge W M, Spielholz C, Baselga J, Vera J C, Golde D W

机构信息

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

J Clin Invest. 1997 Dec 1;100(11):2842-8. doi: 10.1172/JCI119832.

DOI:10.1172/JCI119832
PMID:9389750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC508490/
Abstract

Vitamin C concentrations in the brain exceed those in blood by 10-fold. In both tissues, the vitamin is present primarily in the reduced form, ascorbic acid. We identified the chemical form of vitamin C that readily crosses the blood-brain barrier, and the mechanism of this process. Ascorbic acid was not able to cross the blood-brain barrier in our studies. In contrast, the oxidized form of vitamin C, dehydroascorbic acid (oxidized ascorbic acid), readily entered the brain and was retained in the brain tissue in the form of ascorbic acid. Transport of dehydroascorbic acid into the brain was inhibited by d-glucose, but not by l-glucose. The facilitative glucose transporter, GLUT1, is expressed on endothelial cells at the blood-brain barrier, and is responsible for glucose entry into the brain. This study provides evidence showing that GLUT1 also transports dehydroascorbic acid into the brain. The findings define the transport of dehydroascorbic acid by GLUT1 as a mechanism by which the brain acquires vitamin C, and point to the oxidation of ascorbic acid as a potentially important regulatory step in accumulation of the vitamin by the brain. These results have implications for increasing antioxidant potential in the central nervous system.

摘要

大脑中的维生素C浓度比血液中的高出10倍。在这两种组织中,维生素主要以还原形式即抗坏血酸存在。我们确定了易于穿过血脑屏障的维生素C的化学形式以及这一过程的机制。在我们的研究中,抗坏血酸无法穿过血脑屏障。相比之下,维生素C的氧化形式脱氢抗坏血酸(氧化型抗坏血酸)很容易进入大脑,并以抗坏血酸的形式保留在脑组织中。脱氢抗坏血酸进入大脑的过程受到d-葡萄糖的抑制,但不受l-葡萄糖的抑制。易化型葡萄糖转运体GLUT1在血脑屏障的内皮细胞上表达,负责葡萄糖进入大脑。这项研究提供了证据表明GLUT1也能将脱氢抗坏血酸转运到大脑中。这些发现将GLUT1对脱氢抗坏血酸的转运定义为大脑获取维生素C的一种机制,并指出抗坏血酸的氧化是大脑积累该维生素的一个潜在重要调节步骤。这些结果对提高中枢神经系统的抗氧化能力具有重要意义。

相似文献

1
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters.维生素C以氧化形式通过葡萄糖转运蛋白穿过血脑屏障。
J Clin Invest. 1997 Dec 1;100(11):2842-8. doi: 10.1172/JCI119832.
2
Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells.在人黑素瘤细胞中,脱氢抗坏血酸的易化转运增加,而钠依赖性抗坏血酸盐转运无变化。
Cancer Res. 1997 Jun 15;57(12):2529-37.
3
Vitamin C uptake and recycling among normal and tumor cells from the central nervous system.中枢神经系统正常细胞与肿瘤细胞间的维生素C摄取与循环利用
J Neurosci Res. 2005;79(1-2):146-56. doi: 10.1002/jnr.20326.
4
Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome.葡萄糖转运蛋白综合征中脱氢抗坏血酸转运缺陷。
Ann Neurol. 1998 Aug;44(2):286-7. doi: 10.1002/ana.410440225.
5
Stromal cell oxidation: a mechanism by which tumors obtain vitamin C.基质细胞氧化:肿瘤获取维生素C的一种机制。
Cancer Res. 1999 Sep 15;59(18):4555-8.
6
Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid.哺乳动物易化型己糖转运蛋白介导脱氢抗坏血酸的转运。
Nature. 1993 Jul 1;364(6432):79-82. doi: 10.1038/364079a0.
7
Vitamin C transport in oxidized form across the rat blood-retinal barrier.氧化形式的维生素C跨大鼠血视网膜屏障的转运
Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1232-9. doi: 10.1167/iovs.03-0505.
8
Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid.人HL-60髓系白血病细胞通过葡萄糖转运蛋白转运脱氢抗坏血酸并积累还原型抗坏血酸。
Blood. 1994 Sep 1;84(5):1628-34.
9
Up-regulation and polarized expression of the sodium-ascorbic acid transporter SVCT1 in post-confluent differentiated CaCo-2 cells.汇合后分化的CaCo-2细胞中钠-维生素C转运体SVCT1的上调及极化表达
J Biol Chem. 2003 Mar 14;278(11):9035-41. doi: 10.1074/jbc.M205119200. Epub 2002 Oct 14.
10
Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking of dehydroascorbic acid and ascorbic acid uptakes in HL-60, U937 and Jurkat cells.在HL-60、U937和Jurkat细胞中,类黄酮通过阻断脱氢抗坏血酸和抗坏血酸的摄取来抑制抗坏血酸的细胞内积累。
J Nutr. 2000 May;130(5):1297-302. doi: 10.1093/jn/130.5.1297.

引用本文的文献

1
Synthetic and semi-synthetic antioxidants in medicine and food industry: a review.医药和食品工业中的合成与半合成抗氧化剂:综述
Front Pharmacol. 2025 Jul 22;16:1599816. doi: 10.3389/fphar.2025.1599816. eCollection 2025.
2
Unraveling the nutritional challenges in epilepsy: Risks, deficiencies, and management strategies: A systematic review.解析癫痫中的营养挑战:风险、缺乏症及管理策略:一项系统综述
World J Exp Med. 2025 Jun 20;15(2):104328. doi: 10.5493/wjem.v15.i2.104328.
3
Vitamin C intake and cognitive function in older U.S. adults: nonlinear dose-response associations and effect modification by smoking status.美国老年人的维生素C摄入量与认知功能:非线性剂量反应关联及吸烟状况的效应修正
Front Nutr. 2025 Jun 4;12:1585863. doi: 10.3389/fnut.2025.1585863. eCollection 2025.
4
An overview of regulation for nutraceuticals and concept of personalized nutraceuticals.营养保健品的监管概述及个性化营养保健品的概念。
J Generic Med. 2023 Jun;19(2):66-74. doi: 10.1177/17411343221150875. Epub 2023 Jan 13.
5
Does COVID-19 Trigger the Risk for the Development of Parkinson's Disease? Therapeutic Potential of Vitamin C.COVID-19 是否会引发帕金森病的风险?维生素 C 的治疗潜力。
Mol Neurobiol. 2024 Dec;61(12):9945-9960. doi: 10.1007/s12035-023-03756-3. Epub 2023 Nov 14.
6
GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer.葡萄糖转运蛋白1(GLUT-1)可能预测局部晚期直肠癌患者的转移和死亡情况。
Front Oncol. 2023 Mar 9;13:1094480. doi: 10.3389/fonc.2023.1094480. eCollection 2023.
7
Transporter-Mediated Drug Delivery.载体介导的药物递送。
Molecules. 2023 Jan 24;28(3):1151. doi: 10.3390/molecules28031151.
8
Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell Barrier.鉴定纳米颗粒特性以实现跨生理细胞屏障的最佳药物递送
Pharmaceutics. 2023 Jan 6;15(1):200. doi: 10.3390/pharmaceutics15010200.
9
Blood-Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders.血脑屏障破坏及其在神经发育和神经退行性疾病中的作用。
Int J Mol Sci. 2022 Dec 3;23(23):15271. doi: 10.3390/ijms232315271.
10
Unwinding the potentials of vitamin C in COVID-19 and other diseases: An updated review.维生素 C 在 COVID-19 和其他疾病中的潜力:最新综述。
Nutr Health. 2023 Sep;29(3):415-433. doi: 10.1177/02601060221139628. Epub 2022 Nov 29.

本文引用的文献

1
Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase.硒酶硫氧还蛋白还原酶将脱氢抗坏血酸还原为抗坏血酸。
J Biol Chem. 1997 Sep 5;272(36):22607-10. doi: 10.1074/jbc.272.36.22607.
2
Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione.谷胱甘肽缺失的HL-60细胞中维生素C的高效转运与积累
J Biol Chem. 1997 Apr 11;272(15):9915-21. doi: 10.1074/jbc.272.15.9915.
3
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.健康志愿者体内维生素C的药代动力学:推荐膳食摄入量的证据。
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3704-9. doi: 10.1073/pnas.93.8.3704.
4
Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid.哺乳动物易化型己糖转运蛋白介导脱氢抗坏血酸的转运。
Nature. 1993 Jul 1;364(6432):79-82. doi: 10.1038/364079a0.
5
Cerebral metabolism of oxidized ascorbate.
Brain Res. 1993 Nov 19;628(1-2):49-55. doi: 10.1016/0006-8993(93)90936-h.
6
Ascorbic acid regeneration by bovine iris-ciliary body.
Curr Eye Res. 1993 Jul;12(7):593-601. doi: 10.3109/02713689309001838.
7
Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid.人HL-60髓系白血病细胞通过葡萄糖转运蛋白转运脱氢抗坏血酸并积累还原型抗坏血酸。
Blood. 1994 Sep 1;84(5):1628-34.
8
Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid.脱氢抗坏血酸从其作为抗坏血酸的细胞内积累中促进转运的消退。
J Biol Chem. 1995 Oct 6;270(40):23706-12. doi: 10.1074/jbc.270.40.23706.
9
Expression of a rabbit renal ascorbic acid transporter in Xenopus laevis oocytes.
Am J Physiol. 1994 Jul;267(1 Pt 1):C301-6. doi: 10.1152/ajpcell.1994.267.1.C301.
10
Comparison of radio-labeled butanol and iodoantipyrine as cerebral blood flow markers.
Brain Res. 1981 Oct 19;222(2):365-72. doi: 10.1016/0006-8993(81)91039-8.